No black box warning on record for Deferasirox

As of the latest FDA labeling reviewed, Deferasirox (DEFERASIROX) does not carry a black box warning. Standard warnings and precautions still apply — see the full Deferasirox medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Acute Kidney Injury: Measure serum creatinine in duplicate before starting therapy. Monitor renal function during deferasirox therapy and reduce dose or interrupt therapy for toxicity. ( 2.1 , 2.4 , 5.1 ) Hepatic Toxicity: Monitor hepatic function. Reduce dose or interrupt therapy for toxicity. ( 5.2 ) Fatal and Nonfatal Gastrointestinal (GI) Bleeding, Ulceration, and Ir

No black box warning on record for Deferasirox

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Acute Kidney Injury: Measure serum creatinine in duplicate before starting therapy. Monitor renal function during deferasirox therapy and reduce dose or interrupt therapy for toxicity. ( 2.1 , 2.4 , 5.1 ) Hepatic Toxicity: Monitor hepatic function. Reduce dose or interrupt therapy for toxicity. ( 5.2 ) Fatal and Nonfatal Gastrointestinal (GI) Bleeding, Ulceration, and Ir

Deferasirox Black Box Warning

No black box warning on record for Deferasirox

Other warnings & precautions

Deferasirox Black Box Warning

No black box warning on record for Deferasirox

Other warnings & precautions